№ lp_1_2_61291
File format: docx
Character count: 14043
File size: 147 KB
The document outlines the necessary details for submitting a drug application, including manufacturer, product information, and formulation details for human, veterinary, and disinfectant drugs in Canada.
Note:
Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / City:
United Kingdom
Subject:
Household cleaning product safety
Document Type:
Safety Data Sheet
Organization / Institution:
Thornton & Ross
Author:
Thornton & Ross
Target Audience:
General public, workers in chemical handling
Period of Validity:
Ongoing
Approval Date:
2021
Date of Changes:
None
Year:
2021
Region / City:
Canada
Topic:
Drug Submission Application
Document Type:
Fee Form
Institution:
Health Canada
Author:
Not specified
Target Audience:
Manufacturers, Sponsors
Period of Validity:
2021-2022
Approval Date:
Not specified
Amendment Date:
Not specified
Context:
Document providing details about application fees for drug submissions to Health Canada, including various categories and fee structures.
Year:
Month Year
Region / City:
Texas, USA
Subject:
Water quality and public health
Document Type:
Public notice
Agency:
Texas Commission on Environmental Quality (TCEQ)
Regulation Reference:
30 TAC §290.122
Contaminant:
Chlorine dioxide
Violation Type:
MRDL exceedance
Affected Population:
General public, infants, young children, pregnant women
Distribution System Monitoring:
Not completed
Notice Delivery:
Posted/Delivered within 24 hours and every 90 days until resolved
Topic:
Chemistry of disinfectants and alcohol-based sanitizers
Subject Area:
Chemistry; Public Health
Type of Document:
Educational explanatory text
Author:
Not specified
Institution / Organization Mentioned:
FDA (Food and Drug Administration)
Context:
COVID-19 pandemic
Key Substances Discussed:
Ethanol (ethyl alcohol); Isopropyl alcohol (isopropanol); Water
Related Viruses:
SARS-CoV-2; Influenza virus; Herpes virus; Rhinovirus; Norovirus; HIV
Scientific Concepts:
Enveloped viruses; Nonenveloped viruses; Hydrogen bonding; Protein coagulation; Molecular structure
Purpose:
Explanation of why different alcohol concentrations are used in hand sanitizers
Sources Referenced:
pediaa.com; byjus.com; cancer.gov; ehs.umich.edu; lumenlearning.com; clutchprep.com; fda.gov
Approximate Period:
COVID-19 pandemic era (2020s)
Year:
2026
Region / City:
Nairobi, Kenya
Topic:
Disinfectant and Antiseptic Safety
Document Type:
Safety Data Sheet
Organization / Institution:
SPECTRA CHEMICALS KENYA LIMITED
Manufacturer:
SPECTRA CHEMICALS KENYA LIMITED
Product Name:
Safi Kerol Disinfectant
Intended Use:
General-purpose disinfectant for home and farm use, sterilization of infective materials
Hazard Classification:
GHS Warning, Flammable, Eye and skin irritant
Precautionary Measures:
Eye and skin protection, avoid ingestion and inhalation
Storage Conditions:
Cool, well-ventilated area, away from sunlight and incompatible substances
Disposal Instructions:
Follow local regulations, recycling preferred
UN Hazard Class:
Class 6.1
Note:
Year
Type of Disinfectant:
Free chlorine / Chloramine
Minimum Residual:
0.2 mg/L for free chlorine, 0.5 mg/L for chloramine
Number of Customers:
Fewer than 750
Sampling Frequency:
Weekly for distribution system, monthly with coliform samples
Sample Count:
Up to 5 per worksheet
Data Recorded:
Sample date, sample site, disinfectant residual, below minimum, no residual
Reporting Form:
DLQOR
Purpose:
Monitoring disinfectant levels in small water systems
Year:
2023
Note:
Region / City
Subject:
Billing Requirements for Drugs and Biologicals with Discarded Amounts
Document Type:
Policy
Organization / Institution:
SummaCare, Apex Summa Health Management Company, Summa Insurance Company
Target Audience:
Providers, Healthcare Administrators, Claims Department
Effective Period:
From 01/01/2017
Approval Date:
08/15/2023
Review Date:
Every 2 years or as necessary
Compliance Statement:
All members of the workforce are responsible for compliance with this policy.
Monitoring and Auditing:
Claims Department
Documentation Retention:
Minimum of 10 years
Purpose:
To outline the billing requirements for drugs and biologicals with unused and discarded amounts from single-dose containers or single-use packages.
Description:
Guidelines on proper billing procedures for drugs and biologicals, including the use of JW and JZ modifiers for discarded drug amounts or no wastage in single-dose vials, applicable to providers and insurers.
Year:
2025
Region / City:
Not specified
Theme:
Healthcare, Drug Coverage
Document Type:
Informational Flyer
Organization / Institution:
Wellcare
Author:
Not specified
Target Audience:
Healthcare providers, insurance plan members
Period of Validity:
Not specified
Approval Date:
07/24/2024
Date of Changes:
Not specified
Year:
2021
Region / City:
Australia
Theme:
Mental health, Alcohol and Other Drugs
Document Type:
Unit of competency
Organization / Institution:
Australian Skills Quality Authority (ASQA)
Author:
Not specified
Target Audience:
People working in community services, mental health and alcohol and other drug sectors
Period of validity:
Not specified
Approval Date:
Not specified
Date of modifications:
Release 2, Modification History: Release 2
Note:
Year
Topic:
Clinical Trial Agreement
Document Type:
Contract
Institution / Organization:
Istituto clinico Humanitas
Target Audience:
Medical, Scientific, and Research Professionals
Unit code:
CHCAOD007
Release:
2
Type:
Competency unit
Sector:
Health and community services
Target group:
Workers supporting people with alcohol and other drug challenges
Application:
Relapse prevention and management strategies
Legislation and standards:
Commonwealth and State/Territory legislation, Australian/New Zealand standards, industry codes of practice
Skills:
Relapse prevention planning, risk assessment, harm minimisation, communication, crisis management
Assessment:
Workplace demonstration or simulated environment, treatment plans, risk assessment tools
Knowledge:
Legal and ethical considerations, AOD effects and responses, relapse triggers, support strategies, therapy options, environmental and individual risk factors
Year:
2023
Region:
Scotland
Jurisdiction:
Scotland
Topic:
Management of controlled drugs in primary care
Document type:
Guidance
Version:
3.0
Publication date:
April 2023
Issuing body:
Controlled Drugs Accountable Officers’ Network Scotland
Contributing organisation:
NHS Dumfries & Galloway
Foreword author:
Graeme Bryson
Author role:
Director of Pharmacy
Target audience:
Practitioners working within primary care
Legal framework referenced:
Misuse of Drugs Act 1971; Misuse of Drugs Regulations 2001; Controlled Drugs (Supervision of Management and Use) Regulations 2013
Scope:
Prescribing, supply, administration, storage, recording, monitoring and destruction of controlled drugs
Source type:
Official professional guidance
Note:
Year
Topic:
Incident Reporting
Document Type:
Report Form
Organization:
NHS
Target Audience:
NHS Staff, Contractors
Year:
2023
Region / City:
Southwest London
Theme:
Pharmaceutical Offers, Medicines Access
Document Type:
Template
Organization / Institution:
Southwest London Integrated Care System (SWL ICS)
Author:
Southwest London ICS Pharmacy Team
Target Audience:
Healthcare Professionals, Pharmacists, Medical Staff
Action Period:
Ongoing
Approval Date:
2023-10-01
Amendment Date:
N/A
Contextual Description:
A template outlining procedures for Southwest London Trusts to request approval for commercial offers and deeply discounted medicines, including "Free of Charge" (FOC) schemes based on RMOC guidelines.
Year:
2012
Region / City:
Morgan County, Georgia
Topic:
Legal procedure, DUI test evidence
Document type:
Court brief
Organ / Institution:
Superior Court of Morgan County, Georgia
Author:
N/A
Target Audience:
Legal professionals, court officials
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2019
Region / City:
Victoria, Australia
Topic:
Forensic Alcohol and Other Drugs (AOD) Treatment Services
Document Type:
Government Publication
Organization:
Victorian Government
Author:
Department of Health and Human Services (DHHS) and Department of Justice and Community Safety (DJCS)
Target Audience:
Service providers, professionals in the AOD and correctional sectors
Period of Validity:
Ongoing
Approval Date:
June 2019
Date of Changes:
Not specified